Atlas Trials

Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab

Clinical trial NCT02316327 · COMPLETED

Trial details

NCT number
NCT02316327
Sponsor
Fundacion Clinic per a la Recerca Biomédica
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer (NSCLC)
Start date
2013-07-01
Primary completion
2016-09-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.